Product Images Budesonide Inhalation

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 9 images provide visual information about the product associated with Budesonide Inhalation NDC 68788-8503 by Preferred Pharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Budesonide Inh Susp 0.5mg per2mL - DD74E446 7C1B 4F02 9C73 BA716572EE77 00

Budesonide Inh Susp 0.5mg per2mL - DD74E446 7C1B 4F02 9C73 BA716572EE77 00

This is a description for a medication called Budesonide Inhalation Suspension. The medication is available in a 0.5mg/2mL single-dose ampule. The generic name for this medication is Pulmicort. It is manufactured by Lupin Pharmaceuticals, Inc. It should be stored upright at a temperature between 20° to 25°C (68" to 77°F). The medication should not be frozen and should be protected from light. Once opened, the contents of the ampule should be used immediately. The medication is for inhalation only and should be used as directed by a physician. The description also includes instructions in both English and Spanish.*

chemical structure - e986c849 75fc 4c78 b593 1bd0c878adf8 01

chemical structure - e986c849 75fc 4c78 b593 1bd0c878adf8 01

image - e986c849 75fc 4c78 b593 1bd0c878adf8 02

image - e986c849 75fc 4c78 b593 1bd0c878adf8 02

Nighttime Asthma Change from Baseline was evaluated. The mean change from Baseline for nighttime Asthma Symptoms was measured. The data was collected over a period of 12 weeks. Different dosage levels were administered, including 0.25 mg, 0.5 mg, and 1.0 mg once daily. The p-values for these dosage levels were calculated to be 0.001, 0.010, and 0.009 respectively.*

image - e986c849 75fc 4c78 b593 1bd0c878adf8 03

image - e986c849 75fc 4c78 b593 1bd0c878adf8 03

Nighttime Asthma Change from Baseline: The given text provides information about the mean change from baseline in nighttime asthma symptoms. The values obtained for the change from baseline are 0.1 and 0.0. The data also includes the p-values for different medication dosages: 0.25 mg (p-value: 0.022) and 0.5 mg (p-value: 0.021). However, the information provided is not sufficient to determine the context or significance of these values.*

Image - e986c849 75fc 4c78 b593 1bd0c878adf8 04

Image - e986c849 75fc 4c78 b593 1bd0c878adf8 04

Nighttime Asthma Change from Baseline is a study evaluating the mean change in nighttime asthma symptoms from baseline. The study includes different treatment groups receiving varying dosages of a medication. The placebo group and multiple dosage groups are compared over a period of 12 weeks. The p-values for each dosage group are provided, indicating the statistical significance of the observed changes in symptoms.*

Instructions - e986c849 75fc 4c78 b593 1bd0c878adf8 05

Instructions - e986c849 75fc 4c78 b593 1bd0c878adf8 05

Instructions - e986c849 75fc 4c78 b593 1bd0c878adf8 06

Instructions - e986c849 75fc 4c78 b593 1bd0c878adf8 06

Instructions - e986c849 75fc 4c78 b593 1bd0c878adf8 07

Instructions - e986c849 75fc 4c78 b593 1bd0c878adf8 07

Instructions - e986c849 75fc 4c78 b593 1bd0c878adf8 08

Instructions - e986c849 75fc 4c78 b593 1bd0c878adf8 08

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.